Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.6K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Abnormal Proliferation02:23

Abnormal Proliferation

5.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum Metabolomic Signature of Gliomas in an Indian Cohort: Identification of Grade-Specific Alterations and Potential Biomarkers.

Neurology India·2026
Same author

ALK-positive histiocytosis with isolated central nervous system involvement: Report of two cases and review of a newly described entity.

Clinical neuropathology·2025
Same author

Three cases of pituicytoma with a review of the literature and insight into a rare variant of ependymal pituicytoma.

Clinical neuropathology·2025
Same author

MICU1 related myopathy - a rare report from India.

Journal of neuromuscular diseases·2025
Same author

Adult-Onset Neuronal Ceroid Lipofuscinosis: <i>CLN5</i> Variant Presenting as Focal Dystonia.

Tremor and other hyperkinetic movements (New York, N.Y.)·2024
Same author

Optico-Chiasmatic Distortions in Pituitary Adenomas: Correlation Between Postoperative Morphological Reversal and Follow-Up Functional Visual Recovery.

World neurosurgery·2024

Related Experiment Video

Updated: Mar 24, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.4K

Primary parietal myeloid sarcoma.

Laxminadh Sivaraju1, Dilip Mohan1, Nandita Ghosal2

  • 1Department of Neurosurgery, Sri Sathya Sai Institute of Higher Medical Sciences, Bengaluru, Karnataka, India.

Journal of Pediatric Neurosciences
|March 11, 2016
PubMed
Summary

Intracranial myeloid sarcoma, a rare tumor without systemic disease, can mimic meningioma. This case highlights its distinct presentation and successful treatment with chemotherapy.

Keywords:
Immunohistochemistryintracranialmyeloid sarcomaparietal

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.8K
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.7K

Related Experiment Videos

Last Updated: Mar 24, 2026

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice
07:54

Implantation and Monitoring by PET/CT of an Orthotopic Model of Human Pleural Mesothelioma in Athymic Mice

Published on: December 21, 2019

7.4K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

2.8K
Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
09:21

Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas

Published on: September 13, 2019

7.7K

Area of Science:

  • Neurology
  • Oncology
  • Pathology

Background:

  • Intracranial myeloid sarcoma is rare, especially without systemic hematological disorders.
  • Myeloid sarcoma can present as an extra-axial mass, mimicking other tumors like meningioma.

Observation:

  • A 17-year-old female presented with symptoms of increased intracranial pressure and paraparesis.
  • MRI revealed a large, contrast-enhancing extra-axial mass in the parasagittal region.
  • Subtotal tumor excision was performed, with histology confirming myeloid sarcoma.

Findings:

  • Peripheral blood smear and bone marrow biopsy excluded leukemia and myeloproliferative disorders.
  • The intracranial mass exhibited radiological and intraoperative features similar to meningioma.
  • Immunohistochemistry was crucial for definitive diagnosis of myeloid sarcoma.

Implications:

  • This case underscores the importance of considering myeloid sarcoma in the differential diagnosis of intracranial masses, even in the absence of systemic disease.
  • Early diagnosis and appropriate chemotherapy can lead to significant clinical improvement.
  • Further research into the specific characteristics and management of isolated intracranial myeloid sarcoma is warranted.